Article
Predicting GD2 expression across cancer types by the integration of pathway topology and transcriptome data
2025-05-24
Abstract excerpt
The disialoganglioside GD2 is a key cancer therapy target due to its overexpression in several cancer types and limited expression in normal tissues. We developed a computational framework integrating reaction activity scores derived from transcriptomic data with glycosphingolipid biosynthesis pathway to predict GD2 expression. We labeled specific reactions as GD2-promoting or -mitigating, and used their cumulativ...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 25ca4c5a-bda8-5d45-b952-24d5efccc4d2
- DOI
- 10.1101/2025.05.21.655303
